Potent metabolic sialylation inhibitors based on C-5 modified fluorinated sialic acids

Torben Heise, Johan Pijnenborg, Christian Büll, Niek van Hilten, Esther Kers-Rebel, Natasja Balneger, Hidde Elferink, Gosse J Adema, Thomas J Boltje

18 Citations (Scopus)

Abstract

Sialic acid sugars on mammalian cells regulate numerous biological processes, while aberrant expression of sialic acid is associated with diseases such as cancer and pathogenic infection. Inhibition of the sialic acid biosynthesis may therefore hold considerable therapeutic potential. To effectively decrease the sialic acid expression, we synthesized C-5-modified 3-fluoro sialic acid sialyltransferase inhibitors. We found that C-5 carbamates significantly enhanced and prolonged the inhibitory activity in multiple mouse and human cell lines. As an underlying mechanism, we have identified that carbamate-modified 3-fluoro sialic acid inhibitors are more efficiently metabolized to their active cytidine monophosphate analogues, reaching higher effective inhibitor concentrations inside cells.

Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume62
Issue number2
Pages (from-to)1014-1021
ISSN0022-2623
DOIs
Publication statusPublished - 24 Jan 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Potent metabolic sialylation inhibitors based on C-5 modified fluorinated sialic acids'. Together they form a unique fingerprint.

Cite this